Related Experiment Video
Updated: Jun 22, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
Published on: July 17, 2020
Dual specificity phosphatases in prostate cancer
Yke Jildouw Arnoldussen1, Fahri Saatcioglu
1Department of Molecular Biosciences, University of Oslo, Blindern, 0316 Oslo, Norway.
Abstract:
The mitogen-activated protein kinase (MAPK) pathways have critical roles in growth, differentiation, and cell death. Their activity is regulated by an intricate network of crosstalk with other signaling pathways, as well as more directly by two subgroups of the dual specificity phosphatases (DUSPs), the MAPK phosphatases (MKPs) and atypical DUSPs. Several studies have shown that MAPKs are involved in the development and progression of different cancers; however, their definitive function in carcinogenesis has been difficult to determine to date. MAPK expression is altered in prostate cancer, the most common non-cutaneous cancer in men. There is now increasing evidence that DUSPs have important roles in regulating the MAPK pathways in prostate cancer and may therefore directly affect disease outcome. Changes in expression of DUSPs are correlated with survival and cell death in prostate cancer cells, but a general and consistent mechanism is at present lacking; nevertheless, some themes are emerging. Here we discuss the latest findings on the possible impact of DUSPs on prostate carcinogenesis.
Insights
Dual specificity phosphatases (DUSPs) impact prostate cancer development by regulating mitogen-activated protein kinase (MAPK) pathways. Understanding DUSP roles in MAPK signaling is crucial for determining their effect on prostate carcinogenesis and disease outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Mitogen-activated protein kinase (MAPK) pathways regulate crucial cellular processes like growth, differentiation, and apoptosis.
- MAPK dysregulation is implicated in various cancers, including prostate cancer, the most common non-cutaneous cancer in men.
- Dual specificity phosphatases (DUSPs), including MAPK phosphatases (MKPs) and atypical DUSPs, are key regulators of MAPK activity.
Purpose of the Study:
- To review the emerging roles of DUSPs in regulating MAPK pathways within the context of prostate cancer.
- To discuss the potential impact of DUSPs on prostate carcinogenesis and disease progression.
- To highlight the current understanding and remaining questions regarding DUSP mechanisms in prostate cancer.
Main Methods:
- Literature review of studies investigating MAPK pathways and DUSPs in prostate cancer.
- Analysis of existing evidence on DUSP expression alterations in prostate cancer.
- Synthesis of findings on the correlation between DUSP expression, cell survival, and cell death in prostate cancer cells.
Main Results:
- MAPK pathway alterations are observed in prostate cancer.
- Evidence suggests DUSPs play significant roles in modulating MAPK signaling in prostate cancer.
- Changes in DUSP expression correlate with prostate cancer cell survival and death, though mechanisms are not fully elucidated.
Conclusions:
- DUSPs are emerging as critical regulators in prostate cancer, influencing disease outcome through MAPK pathway modulation.
- Further research is needed to establish consistent mechanisms by which DUSPs affect prostate carcinogenesis.
- Understanding DUSP functions offers potential therapeutic targets for prostate cancer treatment.
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Abnormal Proliferation
Amplifying Signals via Enzymatic Cascade
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
